BioReference buys Roche's prenatal testing business

LabPulse.com staff writers
Aug 15, 2021
2021 06 14 23 12 5436 Test Tube Lab Biomaterials 400

BioReference Laboratories has purchased U.S. Ariosa, Roche's prenatal testing business. U.S. Ariosa offers a noninvasive prenatal screening test called Harmony Prenatal that has been used by more than 1.5 million women.

BioReference offers a similar test, ClariTest Core, through its specialty health division, GenPath, it said; U.S. Ariosa's Harmony Prenatal will round out the company's prenatal screening portfolio.

Latest in Microscopy & Imaging
Mouse Lab Social
New scanning method creates whole-body “atlases” of biological systems
July 13, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Artificial Intelligence Ai Hand
Self-supervised deep learning algorithm shows promise for rapid whole-slide-imaging retrieval
October 19, 2022
Business Man Handshake
Zeiss, Ultivue to co-market spatial phenomics solution
October 12, 2022
Related Stories
Graph Financial Results Tablet Social
Financial Results
Opko Health Q4 revenues drop 54% as BioReference business reduces costs
Hpv Infection Social
Cervical Cancer
BioReference offering Roche Diagnostics cytology test for women at high risk for HPV
Blood Test Samples Lab Social
Guideline
Study suggests race adjustment unnecessary for alpha fetoprotein prenatal testing
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Microscopy & Imaging
New scanning method creates whole-body “atlases” of biological systems
By Matt Limb
wildDISCO can create whole-body “atlases” focusing on the nervous system, lymphatic vessels, blood vessels, and immune cells to highlight normal structures and tumors in early stages of formation.
July 13, 2023
Mouse Lab Social
Convert a smartphone into a fluorescent microscope for under $50
By Elissa Wolfson
Researchers inexpensively convert smartphones into what they describe as “glowscope” microscopes, potentially enabling underserved students to observe living organisms.
March 9, 2023
Human Cells Flow Cytometry Social
Self-supervised deep learning algorithm shows promise for rapid whole-slide-imaging retrieval
By Jared Berberabe
Brigham and Women’s Hospital researchers are developing an algorithm to speed whole-slide-imaging retrieval from large digital repositories.
October 19, 2022
Artificial Intelligence Ai Hand
Zeiss, Ultivue to co-market spatial phenomics solution
By LabPulse.com staff writers
The partners will provide a streamlined solution for processes from tissue preparation to image acquisition and analysis for applications in cancer biology, immunology, and drug development, Zeiss said.
October 12, 2022
Business Man Handshake
Does Tc-99m SPECT damage DNA?
By Will Morton
In a pilot study, researchers studied the effect of ionizing radiation on patients who underwent MPI exams, also known as nuclear stress tests. They used a comet assay, a standard lab test for detecting DNA damage in cells, to analyze patient blood samples before and after they underwent imaging, with results suggesting a small yet likely irrelevant amount of damage.
September 19, 2022
2022 09 19 22 30 6972 2022 09 20 Spect Comet 20220919220954
Boosted by COVID-19 and cancer tests, IVD market reaches $127B: Kalorama
By Bruce Carlson
That's the finding from Kalorama's market research report, The Worldwide Market for In Vitro Diagnostics, 15th edition.
August 25, 2022
2020 02 06 18 18 1550 Business Financial Results 400
Decline in COVID tests pulls down Q3 revenue at Siemens Healthineers
By LabPulse.com staff writers
For the quarter (end-June 30), Siemens Healthineers posted third-quarter revenues of 5.186 billion euros ($5.25 billion), down 5.7% after currency adjustment compared with revenues of 5 billion euros ($5.07 billion) the year before. The company's net income for the quarter was 364 million euros ($369 million), down 8% compared with net income of 395 million euros ($400 million) in the same quarter the year before.
August 2, 2022
2022 02 04 20 07 5010 Siemens Rsna 2021 400
Beckman, Scopio to partner on blood smear platforms
By LabPulse.com staff writers
Scopio's technology employs full-field imaging and artificial intelligence (AI) decision support with the aim of eliminating manual microscopy. The platform allows full-field images to be shared in real-time over a secure hospital network and captures large scan areas at 100X magnification.
July 19, 2022
2020 03 25 23 27 0591 Hands Shaking Deal 400
Etiometry, Radiometer partner to enhance NICU workflows
By LabPulse.com staff writers
The partnership pairs Etiometry's platform for creating holistic views across the patient care continuum with Radiometer's transcutaneous monitoring (TCM) system for monitoring ventilation of neonatal patients.
June 29, 2022
2022 05 10 21 08 4981 Hands Shaking3 400
3D microscope may replace biopsies with real-time imaging
By Leah Sherwood
The system, called MediSCAPE (Swept Confocally Aligned Planar Excitation microscopy), is capable of capturing images of tissue structures that can guide surgeons to navigate tumors and their boundaries without needing to remove tissues and wait for pathology results. If proven in the field, the technology could eventually replace conventional biopsies and histology with real-time imaging within the living body.
March 28, 2022
2022 03 29 14 07 0162 2022 03 29 Mediscape 400
PathAI, Cleveland Clinic to build pathology research infrastructure
By LabPulse.com staff writers
The collaboration will combine PathAI's artificial intelligence (AI)-based platforms with Cleveland Clinic's clinical expertise and multimodal data to implement next-generation pathology diagnostics, PathAI said in a news release.
March 9, 2022
2019 06 06 22 18 6673 Business Man Handshake 400
Insightec to launch new trials of Exablate Neuro
By LabPulse.com staff writers
One study will evaluate the use of Exablate Neuro to treat patients with primary non-small cell lung cancer that has metastasized to the brain in conjunction with Keytruda, a humanized antibody immunotherapy. Exablate Neuro could be used to open up the blood-brain barrier to make immunotherapy agents like Keytruda more effective.
March 9, 2022
2022 03 10 18 19 1134 Mri Head 400
Page 1 of 8
Next Page